AMSC (AMSC) Reports Second Quarter Fiscal Year 2010 Financial Results
Nov. 2, 2010 (Business Wire) — American Superconductor Corporation (NASDAQ: AMSC), a global power technologies company, today reported financial results for the second quarter of its fiscal year 2010 ended September 30, 2010.
Revenues for the second quarter of fiscal 2010 increased 36 percent to $101.5 million from $74.7 million for the second quarter of fiscal 2009. Gross margin for the second quarter of fiscal 2010 was 40.7 percent, which compares with 38.9 percent for the second quarter of fiscal 2009.
AMSC generated net income of $10.0 million, or $0.22 per diluted share, for the second quarter of fiscal 2010. This compares with net income of $4.3 million, or $0.10 per diluted share, for the second quarter of fiscal 2009. Non-GAAP net income was $14.6 million, or $0.32 per diluted share, for the second quarter of fiscal 2010. This compares with non-GAAP net income of $8.7 million, or $0.19 per diluted share, for the second quarter of 2009. Please refer to the financial table included below for a reconciliation of GAAP to non-GAAP results.
Cash, cash equivalents, marketable securities and restricted cash at September 30, 2010 were $131.2 million. This compares with $120.7 million as of June 30, 2010 and $155.1 million as of March 31, 2010.
The company reported backlog as of September 30, 2010 of approximately $956 million compared with approximately $952 million as of June 30, 2010.
“In the second quarter – our fifteenth consecutive quarter of sequential revenue growth – we generated new quarterly records for both gross margin and earnings,” said Greg Yurek, AMSC’s founder and chief executive officer. “In recent weeks, we have achieved a number of additional successes that we believe will enable us to extend our strong track record of profitable growth well beyond fiscal 2010. We strengthened our position in the renewable energy and power grid sectors by making a strategic investment in advanced wind turbine blade manufacturer Blade Dynamics Ltd., and we introduced our new SolarTie™ Grid Interconnection Solution. Most importantly, the second fiscal quarter marked the ‘Coming of Age’ for high temperature superconductors as we booked a three million meter order for our Amperium™ wire – the largest order for high temperature superconductor wire in history.”
Financial Forecast
“We are increasing our fiscal 2010 financial forecast for both revenues and earnings,” said David Henry, AMSC’s senior vice president and chief financial officer. “Our revenue forecast for the full fiscal year has increased from a range of $420 million to $430 million to a range of $430 million to $440 million, representing growth in excess of 36 percent compared with fiscal 2009. Our net income forecast for the full fiscal year has increased from a range of $39.5 million to $42.0 million, or $0.85 to $0.90 per diluted share, to a range of $44.0 million to $46.5 million, or $0.95 to $1.00 per diluted share. Our non-GAAP net income guidance also is being increased from a range of $56.0 million to $58.5 million, or $1.20 to $1.25 per diluted share, to a range of $60.5 million to $63.0 million, or $1.30 to $1.35 per diluted share.”
Conference Call Reminder
In conjunction with this announcement, AMSC management will participate in a conference call with investors beginning at 10:00 a.m. ET today. On this call, management will discuss the dynamics in AMSC’s core markets, recent orders and business initiatives, superconductor power cable opportunities as well as the company’s results and its business outlook. Those who wish to listen to the live conference call webcast should visit the “Investors” section of the company’s website at www.amsc.com/investors. The live call also can be accessed by dialing 785-830-7990 and using conference ID 5168484. A telephonic playback of the call will be available from 1:00 p.m. ET today through 1:00 p.m. ET on November 7. Please call 719-457-0820 and refer to conference ID 5168484 to access the playback.
About American Superconductor (NASDAQ: AMSC)
AMSC offers an array of proprietary technologies and solutions spanning the electric power infrastructure – from generation to delivery to end use. The company is a leader in renewable energy providing proven, megawatt-scale wind turbine designs and electrical control systems. The company also offers a host of Smart Grid technologies for power grid operators that enhance the reliability, efficiency and capacity of the grid, and seamlessly integrate renewable energy sources into the power infrastructure. These include superconductor power cable systems, grid-level surge protectors and power electronics-based voltage stabilization systems. AMSC’s technologies are protected by a broad and deep intellectual property portfolio consisting of hundreds of patents and licenses worldwide. More information is available at www.amsc.com.
American Superconductor and design, Revolutionizing the Way the World Uses Electricity, AMSC, Amperium, Powered by AMSC, D-VAR, dSVC, FaultBlocker, PowerModule, PQ-IVR, PQ-SVC, SuperGEAR, SeaTitan, SolarTie and Windtec and design are trademarks or registered trademarks of American Superconductor Corporation or its subsidiaries. All other brand names, product names or trademarks belong to their respective holders.
Any statements in this release about future expectations, plans and prospects for the company, including our expectations regarding the future financial performance of the company and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There are a number of important factors that could materially impact the value of our common stock or cause actual results to differ materially from those indicated by such forward-looking statements. Such factors include: we have a history of operating losses, and we may incur losses in the future; our operating results may fluctuate significantly from quarter to quarter and may fall below expectations in any particular fiscal quarter; a significant portion of our revenues are derived from a single customer and revenues from this customer may decline in future periods; adverse changes in domestic and global economic conditions could adversely affect our business; changes in exchange rates could adversely affect our financial results; we may not realize all of the sales expected from our backlog of orders and contracts; we rely upon third party suppliers for the components and subassemblies of many of our products, making us vulnerable to supply shortages and price fluctuations; we have not manufactured our Amperium wire in commercial quantities, and a failure to manufacture our Amperium wire in commercial quantities at acceptable cost and quality levels would substantially limit our future revenue and profit potential; and our patents may not provide meaningful protection for our technology, which could result in us losing some or all of our market position. Reference is made to these and other factors discussed in the “Risk Factors” section of the company’s most recent quarterly or annual report filed with the Securities and Exchange Commission. In addition, any forward-looking statements included in this press release represent the company’s views as of the date of this release. While the company anticipates that subsequent events and developments may cause the company’s views to change, the company specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing the company’s views as of any date subsequent to the date this press release is issued.
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||
(In thousands, except per share data) | ||||||||||||||
Three months ended
September 30, |
Six months ended
September 30, |
|||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||
Revenues: | ||||||||||||||
Power Systems | $ | 98,540 | $ | 71,791 | $ | 193,468 | $ | 142,487 | ||||||
Superconductors | 2,989 | 2,881 | 5,271 | 5,185 | ||||||||||
Total revenues | 101,529 | 74,672 | 198,739 | 147,672 | ||||||||||
Cost of revenues | 60,226 | 45,637 | 118,450 | 96,054 | ||||||||||
Gross profit | 41,303 | 29,035 | 80,289 | 51,618 | ||||||||||
Operating expenses: | ||||||||||||||
Research and development | 7,857 | 5,416 | 15,192 | 9,944 | ||||||||||
Selling, general and administrative | 17,127 | 12,712 | 32,310 | 23,597 | ||||||||||
Amortization of acquisition related intangibles | 374 | 460 | 762 | 905 | ||||||||||
Restructuring and impairments | — | 117 | — | 451 | ||||||||||
Total operating expenses | 25,358 | 18,705 | 48,264 | 34,897 | ||||||||||
Operating income | 15,945 | 10,330 | 32,025 | 16,721 | ||||||||||
Interest income | 191 | 190 | 367 | 433 | ||||||||||
Other income (expense), net | 2,448 | (871 | ) | 2,618 | (2,847 | ) | ||||||||
Income before income tax expense | 18,584 | 9,649 | 35,010 | 14,307 | ||||||||||
Income tax expense | 8,596 | 5,309 | 15,853 | 8,175 | ||||||||||
Net income | $ | 9,988 | $ | 4,340 | $ | 19,157 | $ | 6,132 | ||||||
Net income per common share | ||||||||||||||
Basic | $ | 0.22 | $ | 0.10 | $ | 0.42 | $ | 0.14 | ||||||
Diluted | $ | 0.22 | $ | 0.10 | $ | 0.42 | $ | 0.14 | ||||||
Weighted average number of common shares outstanding | ||||||||||||||
Basic | 45,482 | 44,247 | 45,363 | 44,020 | ||||||||||
Diluted | 46,217 | 45,233 | 46,099 | 44,922 | ||||||||||
UNAUDITED CONSOLIDATED BALANCE SHEETS | ||||||||
(In thousands) | ||||||||
September 30, | March 31, | |||||||
2010 | 2010 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 52,615 | $ | 87,594 | ||||
Marketable securities | 69,218 | 54,469 | ||||||
Accounts receivable, net | 96,042 | 62,203 | ||||||
Inventory | 45,241 | 35,858 | ||||||
Prepaid expenses and other current assets | 21,357 | 15,381 | ||||||
Restricted cash | 5,484 | 5,713 | ||||||
Deferred tax assets | 3,117 | 1,776 | ||||||
Total current assets | 293,074 | 262,994 | ||||||
Property, plant and equipment, net | 78,160 | 64,315 | ||||||
Goodwill | 47,508 | 36,696 | ||||||
Intangibles, net | 7,966 | 7,770 | ||||||
Marketable securities | 3,900 | 7,342 | ||||||
Deferred tax assets | 4,121 | 3,043 | ||||||
Other assets | 30,506 | 18,024 | ||||||
Total assets | $ | 465,235 | $ | 400,184 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable and accrued expenses | $ | 94,184 | $ | 84,319 | ||||
Deferred revenue | 25,113 | 19,970 | ||||||
Deferred tax liabilities | 1,580 | 471 | ||||||
Total current liabilities | 120,877 | 104,760 | ||||||
Non-current liabilities | ||||||||
Deferred revenue | 16,433 | 13,302 | ||||||
Deferred tax liabilities | 1,929 | 777 | ||||||
Other | 418 | 380 | ||||||
Total liabilities | 139,657 | 119,219 | ||||||
Stockholders’ equity: | ||||||||
Common stock | 456 | 448 | ||||||
Additional paid-in capital | 718,411 | 698,417 | ||||||
Accumulated other comprehensive loss | (1,557 | ) | (7,011 | ) | ||||
Accumulated deficit | (391,732 | ) | (410,889 | ) | ||||
Total stockholders’ equity | 325,578 | 280,965 | ||||||
Total liabilities and stockholders’ equity | $ | 465,235 | $ | 400,184 | ||||
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) |
||||||||
Six months ended September 30, | ||||||||
2010 | 2009 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 19,157 | $ | 6,132 | ||||
Adjustments to reconcile net income to net cash (used in) provided by operations: | ||||||||
Depreciation and amortization | 5,428 | 4,704 | ||||||
Stock-based compensation expense | 7,825 | 6,918 | ||||||
Stock-based compensation expense—non-employee | 181 | 30 | ||||||
Allowance for doubtful accounts | 959 | 52 | ||||||
Deferred income taxes | (71 | ) | (1,111 | ) | ||||
Other non-cash items | 1,107 | 382 | ||||||
Changes in operating asset and liability accounts: | ||||||||
Accounts receivable | (36,953 | ) | 3,010 | |||||
Inventory | (8,934 | ) | 6,235 | |||||
Prepaid expenses and other current assets | (6,408 | ) | 712 | |||||
Accounts payable and accrued expenses | 8,011 | (4,810 | ) | |||||
Deferred revenue | 7,820 | (567 | ) | |||||
Net cash (used in) provided by operating activities | (1,878 | ) | 21,687 | |||||
Cash flows from investing activities: | ||||||||
Purchase of property, plant and equipment | (17,950 | ) | (2,741 | ) | ||||
Purchase of marketable securities | (25,283 | ) | (40,533 | ) | ||||
Proceeds from the maturity of marketable securities | 15,482 | 33,374 | ||||||
Change in restricted cash | 253 | (546 | ) | |||||
Purchase of intangible assets | (1,615 | ) | (843 | ) | ||||
Purchase of minority investment | (8,000 | ) | — | |||||
Change in other assets | (182 | ) | (617 | ) | ||||
Net cash used in investing activities | (37,295 | ) | (11,906 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of employee stock options | 1,574 | 4,068 | ||||||
Net cash provided by financing activities | 1,574 | 4,068 | ||||||
Effect of exchange rate changes on cash and cash equivalents | 2,620 | 2,229 | ||||||
Net (decrease) increase in cash and cash equivalents | (34,979 | ) | 16,078 | |||||
Cash and cash equivalents at beginning of period | 87,594 | 70,674 | ||||||
Cash and cash equivalents at end of period | $ | 52,615 | $ | 86,752 | ||||
Reconciliation of GAAP Net Income to Non-GAAP Net Income | ||||||||||||||||
(In thousands, except per share data) | ||||||||||||||||
Three months ended
September 30, |
Six months ended
September 30, |
|||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Net income | $ | 9,988 | $ | 4,340 | $ | 19,157 | $ | 6,132 | ||||||||
Amortization of acquisition-related intangibles | 374 | 460 | 762 | 905 | ||||||||||||
Restructuring and impairments | 0 | 117 | 0 | 451 | ||||||||||||
Stock-based compensation | 4,326 | 3,852 | 7,825 | 6,918 | ||||||||||||
Tax effects | (84 | ) | (93 | ) | (167 | ) | (181 | ) | ||||||||
Non-GAAP net income | $ | 14,604 | $ | 8,676 | $ | 27,577 | $ | 14,225 | ||||||||
Non-GAAP earnings per share | $ | 0.32 | $ | 0.19 | $ | 0.60 | $ | 0.32 | ||||||||
Weighted average diluted shares outstanding | 46,217 | 45,233 | 46,099 | 44,922 | ||||||||||||
Reconciliation of Forecast GAAP Net Income to Non-GAAP Net Income for Fiscal Year 2010 | ||||||||
(In millions, except per share data) | ||||||||
Low | High | |||||||
Net Income | $ | 44.0 | $ | 46.5 | ||||
Amortization of acquisition-related intangibles | 1.6 | 1.6 | ||||||
Stock-based compensation | 15.3 | 15.3 | ||||||
Tax effects | (0.4 | ) | (0.4 | ) | ||||
Non-GAAP net income | $ | 60.5 | $ | 63.0 | ||||
Non-GAAP net income per share | $ | 1.30 | $ | 1.35 | ||||
Diluted shares outstanding | 46.7 | 46.7 | ||||||
Note: Non-GAAP net income (loss) is defined by the company as net income (loss) before amortization of acquisition-related intangibles, restructuring and impairments, stock-based compensation, other unusual charges and any tax effects related to these items. The company believes non-GAAP net income (loss) is an important measurement for management and investors given the effect that these non-cash or non-recurring charges have on the company’s net income (loss). The company regards non-GAAP net income (loss) as a useful measure of operating performance and cash flow to complement operating income, net income (loss) and other GAAP financial performance measures.
Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures included in this release, however, should be considered in addition to, and not as a substitute for or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of non-GAAP to GAAP net income is set forth in the table above.
AMSC Contact:
Jason Fredette, 978-842-3177
Managing Director, Corporate Communications
TraderPower Featured Companies
- Annovis Bio Inc. (NYSE: ANVS)
- Astrotech Corp. (NASDAQ: ASTC)
- Cepton Inc. (NASDAQ: CPTN)
- Clene Inc. (NASDAQ: CLNN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)
- Fintech Ecosystem Development Corp. (NASDAQ: FEXD)
- Freight Technologies Inc. (NASDAQ: FRGT)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Top Small Cap Market News
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
Recent Posts
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $FLGC CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space
Recent Comments
Archives
- August 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009